表紙:聴覚機器の世界市場-2023年~2030年
市場調査レポート
商品コード
1373381

聴覚機器の世界市場-2023年~2030年

Global Audiology Devices Market - 2023-2030

出版日: | 発行: DataM Intelligence | ページ情報: 英文 186 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
聴覚機器の世界市場-2023年~2030年
出版日: 2023年10月18日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

難聴は、脳から耳への神経経路の変化により、高齢者に起こりやすいです。聴力検査機器は、難聴や聴覚異常を検出し、治療するために使用されます。聴力検査機器は一般的に補聴器として知られ、人々の聴力問題をモニターし研究するために使用されます。

補聴器、人工内耳、骨固定型聴覚インプラントはすべて、難聴の人々をサポートします。補聴器は、内蔵のマイク、アンプ、スピーカーを使って音を増幅します。補聴器は、聴覚障害を持つ人々を支援するために設計された、音を増幅する装置です。

市場力学:市場促進要因と市場抑制要因

機器発売数の増加

高度に先進的な機器の発売数の増加は、高い効率で聴覚ソリューションを提供する能力により、市場の成長を促進すると予想されます。

例えば、2023年9月25日、AIを搭載した補聴器とオーディオソリューションを提供するELEHEAR社は、初のOTC補聴器デバイスを発表しました。

2023年8月7日、ユニトロンは、最近発売されたビバンテ・プラットフォーム上で動作する新しい充電式補聴器Moxi V-RSを発売しました。

さらに、2022年10月17日、レキシーヒアリングは、ボーズ搭載のレキシーB2補聴器を発売し、同社のオーディオロジスト品質の補聴器製品群に第3の補聴器モデルを追加しました。さらに、難聴患者の増加や製品の技術的進歩も市場成長の原動力となっています。

阻害要因

補聴器にかかるコストの高さ

人工内耳の平均費用は、保険なしで3万米ドルから5万米ドルに及ぶ。そのため、ほとんどの人が高額な人工内耳を購入することができず、市場成長の妨げとなっています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • デバイス発売数の増加
      • 前年比
    • 抑制要因
      • デバイスに関連する高コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMI意見

第6章 COVID-19分析

第7章 テクノロジー別

  • デジタル
  • アナログ

第8章 製品タイプ別

  • 補聴器
  • 人工内耳
  • 骨伝導デバイス
  • 診断機器

第9章 適応症別

  • 耳硬化症
  • メニエール病
  • 音響腫瘍
  • 中耳炎
  • その他

第10章 流通チャネル別

  • 小売販売
  • オンラインストア
  • 政府購入
  • eコマース
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Oticon Medical
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Med-EL
  • Starkey Hearing Technologies
  • Phonak
  • Advanced Bionics
  • Audina Hearing Instruments, Inc.
  • Coselgi
  • Sonova AG
  • WS Audiology A/S
  • BHM-Tech Produktionsgesellschaft mbH

第14章 付録

目次
Product Code: MD1661

Overview

Hearing loss is more likely in elderly people due to alterations in the neurological route from the brain to the ear. Audiology devices are used to detect and treat hearing loss or abnormalities. Audiology devices are commonly known as hearing aids and are used to monitor and study hearing issues in people.

Hearing aids, cochlear implants, and bone-anchored auditory implants all help people with hearing loss. A hearing aid amplifies sound using a built-in microphone, amplifier, and speaker. These are sound-amplifying devices designed to aid people who have a hearing impairment.

Market Dynamics: Drivers & Restraints

Increase in the number of device launches

The increase in the number of highly advanced device launches is expected to drive market growth due to their ability to provide hearing solutions with high efficiency.

For instance, on September 25, 2023, ELEHEAR, a provider of AI-powered hearing aids and audio solutions, introduced its first OTC hearing aid devices, these include the ELEHEAR Alpha and ELEHEAR Alpha Pro.

On August 7, 2023, Unitron launched Moxi V-RS, a new rechargeable hearing device, that operates on the company's recently launched Vivante platform.

Additionally, on October 17, 2022, Lexie Hearing launched the Lexie B2 Hearing Aids, Powered by Bose, adding a third hearing aid model to its suite of audiologist-quality hearing aid products. Furthermore, the increase in the number of patients with hearing loss, and technological advancements of the products also drive the market growth.

Restraint

High costs associated with the devices

The average cost of cochlear implants can range from $30,000 to $50,000 without insurance. Thus, most people cannot afford the devices due to their high cost, which can hamper the market growth.

Segment Analysis

The global audiology devices market is segmented based on technology, product type, indication, distribution channel and region.

Cochlear implants segment accounted for 56.3% of the market share

Cochlear implants segment has been holding a significant position in the market share. Cochlear implants are electronic devices that improve hearing in people who have severe hearing loss due to damage to the inner ear. The increase in the launches of advanced cochlear devices is expected to drive the growth of the segment.

For instance on August 18, 2023, Cochlear Limited, introduced its next-generation Cochlear Osia System with the ability to have an MRI at 3.0 T, designed to improve hearing outcomes for people with conductive hearing loss.

For instance, in August 2021, Cochlear Limited launched the Nucleus Kanso 2 Sound Processor in Singapore. The new launch reflects Cochlear's ongoing commitment to innovation in hearing technology to provide amplified access to smartphone connectivity and help to improve hearing performance in people with hearing loss. Thus, the increased launches of advanced products that help with hearing are expected to drive the segment growth.

Geographical Analysis

North America is expected to hold a significant position in the global audiology devices market share

North America has been a dominant force in the audiology devices market owing to the increase in the number of hearing issues. The increase in the aged population and the presence of a number of medical device manufacturers in the region also act as the driving factors of the market growth in the region. It is expected to continue throughout the forecast period.

For instance, according to the report published by the National Council on Aging, Inc. in 2023, it is estimated that 48 million Americans currently experience hearing loss to some degree. The number of Americans with hearing loss is expected to increase by 30 million in the next four decades.

Additionally, according to the article published by the National Institute of Health in March 2022, Otosclerosis affects more than three million Americans. Many cases of otosclerosis are thought to be inherited. Otosclerosis is a condition in which the bones inside the ear cause gradual hearing loss. Thus, increase in the number of cases with hearing loss increases the demand for the audiology devices, which is expected to drive the market growth.

COVID-19 Impact Analysis:

The pandemic has significantly impacted the global audiology device market. Patients with routine consultation and follow-up care were interrupted due to hospitals delivering only emergency services. Therefore, many patients were neglected from hearing disorder treatment as it is considered as a non-emergency treatment. Thus, COVID-19 has impacted negatively on the market growth.

Competitive Landscape

The leading companies with a significant market share include: Oticon Medical, Med-EL, Starkey Hearing Technologies, Phonak, Advanced Bionics, Audina Hearing Instruments, Inc., Coselgi, Sonova AG, WS Audiology A/S, and BHM-Tech Produktionsgesellschaft mbH among others.

Key Developments

  • On August 29, 2023, Lucid Hearing launched its Tala over-the-counter (OTC) hearing aid product line. Texas-based Lucid Hearing designed Tala with Bluetooth-compatible wireless streaming.
  • On June 21, 2023, Sonova launched its first OTC hearing aid with an "In-Clinic Care Package" Option.
  • On November 1, 2022, Cochlear Limited received the U.S. Food and Drug Administration (FDA) approval for the CochlearTM Nucleus 8 Sound Processor.

Why Purchase the Report?

  • To visualize the global audiology devices market segmentation based on technology, product type, indication, distribution channel and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of audiology devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global audiology devices market report would provide approximately 69 tables, 71 figures, and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Technology
  • 3.2. Snippet by Product Type
  • 3.3. Snippet by Indication
  • 3.4. Snippet by Distribution Channel
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in the number of device launches
      • 4.1.1.2.
    • 4.1.2. Restraints
      • 4.1.2.1. High costs associated with the devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Digital *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Analog

8. By Product Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2. Market Attractiveness Index, By Product Type
  • 8.2. Hearing Aids *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Cochlear Implants
  • 8.4. Bone Conduction Devices
  • 8.5. Diagnostic Devices

9. By Indication

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 9.1.2. Market Attractiveness Index, By Indication
  • 9.2. Otosclerosis *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Meniere's Disease
  • 9.4. Acoustic Tumors
  • 9.5. Otitis Media
  • 9.6. Others

10. By Distribution Channel

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.1.2. Market Attractiveness Index, By Distribution Channel
  • 10.2. Retail Sales *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Online Stores
  • 10.4. Government Purchases
  • 10.5. E-Commerce
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Oticon Medical *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Med-EL
  • 13.3. Starkey Hearing Technologies
  • 13.4. Phonak
  • 13.5. Advanced Bionics
  • 13.6. Audina Hearing Instruments, Inc.
  • 13.7. Coselgi
  • 13.8. Sonova AG
  • 13.9. WS Audiology A/S
  • 13.10. BHM-Tech Produktionsgesellschaft mbH

LIST NOT EXHAUSTIVE.

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us